Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2016-06-28 Annual Report
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
11-K
Annual Report Classification · 95% confidence The document is a Form 11-K filed with the SEC, which is an annual report for employee stock purchase, savings, and similar plans. It includes audited financial statements, notes, and a report from an independent registered public accounting firm. The document covers the fiscal year ended December 31, 2015, and contains detailed financial data and disclosures about the Baxter International Inc. Incentive Investment Plan. The presence of audited financial statements and the nature of Form 11-K indicate this is a comprehensive annual report for an employee benefit plan, which aligns with the definition of an Annual Report (10-K) type filing in the context of employee benefit plans. Therefore, the appropriate classification is 10-K with high confidence.
2016-06-28 English
PRIMARY DOCUMENT
Director's Dealing
2016-06-27 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on a material modification to the rights of security holders, specifically the validation of a Charter Amendment related to the declassification of the board of directors. It includes references to court proceedings and amendments to the certificate of incorporation. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a proxy statement, earnings release, or management discussion. It is a regulatory announcement of a corporate governance event filed as a current report. Given the nature and format, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-06-23 English
PRIMARY DOCUMENT
Director's Dealing
2016-06-21 English
FORM 4 SUBMISSION
Director's Dealing
2016-06-08 English
FORM 4 SUBMISSION
Director's Dealing
2016-06-08 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.